시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 바이오마커 탐색 아웃소싱 서비스 시장 보고서(2025년)
Biomarker Discovery Outsourcing Services Global Market Report 2025
상품코드 : 1702949
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,301,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,108,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,914,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오마커 탐색 아웃소싱 서비스 시장 규모는 향후 몇 년 동안 연평균 16.4%의 성장률을 보이며 2029년에는 312억 2,000만 달러 규모로 성장할 것으로 예측됩니다. 예측 기간 동안의 성장은 개인 맞춤형 의료의 확대, AI와 머신러닝의 통합, 정밀 종양학의 성장, 바이오마커 검증 서비스, 규제 지원, 표적 치료 수요, 환자 중심 의료에 기인하는 것으로 보입니다. 예측 기간 동안 세계 트렌드에는 정밀의료 채택 확대, 기술 발전, 동반진단 수요 증가, 의약품 개발 파이프라인 확대, 비전통적 질환 영역에서의 새로운 응용, 인공지능(AI)과 머신러닝(ML) 통합, 규제 지원 및 표준화, 세계 시장 확대, 파트너십 및 제휴, 비용 및 시간 효율성 강조 등이 포함됩니다.

개인 맞춤형 의료가 강조되면서 바이오마커 탐색 아웃소싱 서비스 시장의 성장이 촉진되고 있습니다. 개인맞춤의료는 정확한 헬스케어 결과와 부작용 감소를 위해 유전적 요인, 생활습관 요인, 환경적 요인을 고려하면서 환자 개개인의 특성에 맞는 치료를 하는 것입니다. 바이오마커 탐색 서비스 아웃소싱은 환자 고유의 생물학적 마커를 기반으로 맞춤형 진단 및 치료 솔루션을 제공함으로써 맞춤의료의 진전을 지원합니다. 예를 들어, Personalized Medicine Coalition의 보고서에 따르면, FDA는 2024년 2월 희귀질환 환자를 위한 16개의 새로운 맞춤 치료제를 승인했으며, 이는 2022년 6건에서 증가한 수치입니다. 이러한 개인맞춤형 치료제의 급증은 개인맞춤형 의료에 대한 관심이 높아지면서 바이오마커 탐색 아웃소싱 서비스에 대한 수요를 촉진하고 있습니다.

바이오마커 탐색 아웃소싱 서비스 시장의 주요 업체들은 환자의 예후를 개선하고 바이오마커 탐색의 진전을 촉진하기 위해 면역단백질체학 발굴 플랫폼과 같은 다중화 바이오마커 분석 개발에 주력하고 있습니다. 면역 단백질체학 탐색 플랫폼은 면역학과 단백질체학를 결합하여 면역 반응과 관련된 단백질을 식별하고 분석합니다. 예를 들어, Sengenics Corporation LLC는 2023년 10월에 면역단백질체학 디스커버리 플랫폼을 출시하여 질병 관련 자가항체 분석을 위한 종합적인 단백질 마이크로어레이 플랫폼을 제공합니다. 이 플랫폼은 면역 바이오마커 탐색을 지원하고, 학계와 임상 바이오제약 부문의 연구팀이 단백질 상호작용과 질병 동역학을 더 잘 이해할 수 있도록 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Biomarker discovery outsourcing services refer to specialized services provided by external organizations or companies that assist in identifying, validating, and developing biomarkers. These services play a crucial role in advancing personalized medicine by enabling the identification of biological markers that can guide diagnosis, prognosis, and therapeutic decisions tailored to individual patients.

The main types of biomarker discovery outsourcing services include predictive biomarkers, prognostic biomarkers, safety biomarkers, and surrogate endpoints. Predictive biomarkers are biological indicators used to identify which patients are likely to benefit from a specific therapeutic intervention. The discovery phases encompass biomarker identification, validation, profiling, panel development, and selection, catering to therapeutic areas such as oncology, cardiology, neurology, autoimmune diseases, and others. End users of these services primarily include pharmaceutical and biotechnology companies.

The biomarker discovery outsourcing services market research report is one of a series of new reports from The Business Research Company that provides biomarker discovery outsourcing services market statistics, including biomarker discovery outsourcing services industry global market size, regional shares, competitors with an biomarker discovery outsourcing services market share, detailed biomarker discovery outsourcing services market segments, market trends and opportunities, and any further data you may need to thrive in the biomarker discovery outsourcing services industry. This biomarker discovery outsourcing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomarker discovery outsourcing services market size has grown rapidly in recent years. It will grow from $14.58 billion in 2024 to $17.01 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to increasing disease burden, pharmaceutical R&D demand, the regulatory environment, cost-effective solutions, research collaboration, and globalization.

The biomarker discovery outsourcing services market size is expected to see rapid growth in the next few years. It will grow to $31.22 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to personalized medicine expansion, AI and machine learning integration, precision oncology growth, biomarker validation services, regulatory support, targeted therapy demand, and patient-centric healthcare. Major trends in the forecast period include increased adoption of precision medicine, technological advancements, rising demand for companion diagnostics, expansion of drug development pipelines, emerging applications in non-traditional disease areas, integration of artificial intelligence (AI) and machine learning (ML), regulatory support and standardization, global market expansion, partnerships and collaborations, and a and a focus on cost-effectiveness and time efficiency.

The increasing emphasis on personalized medicine is set to drive the growth of the biomarker discovery outsourcing services market. Personalized medicine tailors medical treatment to each patient's individual characteristics, considering genetic, lifestyle, and environmental factors for precise healthcare outcomes and reduced adverse effects. Outsourcing biomarker discovery services supports the advancement of personalized medicine by offering customized diagnostic and therapeutic solutions based on patients' unique biological markers. For example, in February 2024, the FDA approved 16 new personalized treatments for rare disease patients, marking an increase from six approvals in 2022, as reported by the Personalized Medicine Coalition. This surge in personalized treatments highlights the growing focus on personalized medicine, fueling the demand for biomarker discovery outsourcing services.

Leading companies in the biomarker discovery outsourcing services market are concentrating on developing multiplexed biomarker assays, such as the immunoproteomic discovery platform, to enhance patient outcomes and drive advancements in biomarker discovery. The immunoproteomic discovery platform combines immunology and proteomics to identify and analyze proteins linked to the immune response. For instance, Sengenics Corporation LLC launched the immunoproteomic discovery platform in October 2023, offering a comprehensive protein microarray platform for analyzing disease-associated autoantibodies. This platform aids in immune biomarker discovery, supporting research teams in academia and clinical biopharmaceutical sectors to better understand protein interactions and disease dynamics.

In August 2022, Fujirebio Holdings Inc., a Japan-based company specializing in diagnostics, acquired ADx NeuroSciences for $44 million. This acquisition enables Fujirebio to expand its portfolio of in vitro diagnostics and enhance its expertise in biomarker development, with the goal of accelerating innovations in neurological testing. ADx NeuroSciences is a Belgium-based company that specializes in biomarker discovery assays and outsourcing services.

Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.

North America was the largest region in the biomarker discovery outsourcing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biomarker discovery outsourcing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biomarker discovery outsourcing services market includes revenues earned by entities through validation and verification studies, clinical sample analysis, bioinformatics, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomarker Discovery Outsourcing Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomarker discovery outsourcing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biomarker discovery outsourcing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomarker discovery outsourcing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Biomarker Discovery Outsourcing Services Market Characteristics

3. Biomarker Discovery Outsourcing Services Market Trends And Strategies

4. Biomarker Discovery Outsourcing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biomarker Discovery Outsourcing Services Growth Analysis And Strategic Analysis Framework

6. Biomarker Discovery Outsourcing Services Market Segmentation

7. Biomarker Discovery Outsourcing Services Market Regional And Country Analysis

8. Asia-Pacific Biomarker Discovery Outsourcing Services Market

9. China Biomarker Discovery Outsourcing Services Market

10. India Biomarker Discovery Outsourcing Services Market

11. Japan Biomarker Discovery Outsourcing Services Market

12. Australia Biomarker Discovery Outsourcing Services Market

13. Indonesia Biomarker Discovery Outsourcing Services Market

14. South Korea Biomarker Discovery Outsourcing Services Market

15. Western Europe Biomarker Discovery Outsourcing Services Market

16. UK Biomarker Discovery Outsourcing Services Market

17. Germany Biomarker Discovery Outsourcing Services Market

18. France Biomarker Discovery Outsourcing Services Market

19. Italy Biomarker Discovery Outsourcing Services Market

20. Spain Biomarker Discovery Outsourcing Services Market

21. Eastern Europe Biomarker Discovery Outsourcing Services Market

22. Russia Biomarker Discovery Outsourcing Services Market

23. North America Biomarker Discovery Outsourcing Services Market

24. USA Biomarker Discovery Outsourcing Services Market

25. Canada Biomarker Discovery Outsourcing Services Market

26. South America Biomarker Discovery Outsourcing Services Market

27. Brazil Biomarker Discovery Outsourcing Services Market

28. Middle East Biomarker Discovery Outsourcing Services Market

29. Africa Biomarker Discovery Outsourcing Services Market

30. Biomarker Discovery Outsourcing Services Market Competitive Landscape And Company Profiles

31. Biomarker Discovery Outsourcing Services Market Other Major And Innovative Companies

32. Global Biomarker Discovery Outsourcing Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomarker Discovery Outsourcing Services Market

34. Recent Developments In The Biomarker Discovery Outsourcing Services Market

35. Biomarker Discovery Outsourcing Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기